P. Ghosh, A. Pal, A. Shavrin, W. Bornmann, J. G. Gelovani and M. M. Alauddin Pages 503 - 512 ( 10 )
N3-Substitued thymidine analogues that carry a carboranylalkyl moiety at the N3-position with various spacer lengths have been reported to be good substrates for thymidine kinase (TK1). As part of our continuing effort towards the development of new TK1 substrates for imaging tumor proliferative activity, we have synthesized a series of new N3- substituted analogues of thymidine that carry an aromatic ring with different spacer lengths. The overall yields for 6 and 7 were 13% and 39% in four steps and three steps, respectively, and those for 14, 16 and 18 were in the range of 13%-15% in six steps. The overall yield for 24 was 33% in three steps, and those for 25 and 26 were 64% and 58%, respectively, in one step. Most of these compounds have been tested for TK1 activity by enzymatic assay to identify a good substrate that can be radiolabeled for imaging. The phosphorylation rates of these compounds were 2%-6% compared with that of thymidine. The results from the in vitro enzymatic assays suggest that these N3-substituted thymidine analogues have some potential for imaging TK1 activity if radiolabeled with a suitable isotope.
Nucleoside analogues, N3-substituted thymidine, thymidine kinase, TK1, ATP
Department of Experimental Diagnostic Imaging, T8.3895, Box 059, The University of Texas M. D.Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.